These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7873314)

  • 1. Topical antibiotics and gastric flora.
    Marsh BT
    Br Dent J; 1995 Feb; 178(3):94. PubMed ID: 7873314
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical antibiotics and gastric flora.
    Kilian M
    Br Dent J; 1995 Feb; 178(3):94. PubMed ID: 7873313
    [No Abstract]   [Full Text] [Related]  

  • 3. The local drug delivery of tetracycline, metronidazole, and chlorhexidine in periodontal therapy.
    Levin-Goldstein D
    J Dent Hyg; 1992; 66(9):410-6. PubMed ID: 1298810
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical antibiotics and gastric flora.
    Cunniffe JG
    Br Dent J; 1994 Oct; 177(7):241. PubMed ID: 7917630
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.
    Kim JJ; Reddy R; Lee M; Kim JG; El-Zaatari FA; Osato MS; Graham DY; Kwon DH
    J Antimicrob Chemother; 2001 Apr; 47(4):459-61. PubMed ID: 11266421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB
    Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults.
    Peretz A; Paritsky M; Nasser O; Brodsky D; Glyatman T; Segal S; On A
    J Antibiot (Tokyo); 2014 Aug; 67(8):555-7. PubMed ID: 24781955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal disease.
    Deasy PB; Collins AE; MacCarthy DJ; Russell RJ
    J Pharm Pharmacol; 1989 Oct; 41(10):694-9. PubMed ID: 2575147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
    Lahaie R; Farley A; Dallaire C; Archambault A; Fallone CA; Ponich T; Hunt R; Oravec M; Whitsitt P; Van Zanten SV; Marcon N; Bailey R; Dumont A; Nguyen B; Desrochers S; Spénard J
    Can J Gastroenterol; 2001 Sep; 15(9):581-5. PubMed ID: 11573100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and metronidazole resistance.
    Weil J; Bell GD; Powell K; Jobson R; Trowell JE; Gant P; Jones PH
    Lancet; 1990 Dec; 336(8728):1445. PubMed ID: 1978897
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of metronidazole resistance on the eradication of Helicobacter pylori.
    Noach LA; Langenberg WL; Bertola MA; Dankert J; Tytgat GN
    Scand J Infect Dis; 1994; 26(3):321-7. PubMed ID: 7939433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
    Debets-Ossenkopp YJ; Herscheid AJ; Pot RG; Kuipers EJ; Kusters JG; Vandenbroucke-Grauls CM
    J Antimicrob Chemother; 1999 Apr; 43(4):511-5. PubMed ID: 10350380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
    Coudron PE; Stratton CW
    J Antimicrob Chemother; 1998 Nov; 42(5):657-60. PubMed ID: 9848452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain.
    López-Brea M; Domingo D; Sanchez I; Alarcon T
    J Antimicrob Chemother; 1997 Aug; 40(2):279-81. PubMed ID: 9301996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drugs in the prevention and therapy of periodontal diseases. II. Systemic administration--antibiotics].
    Andronikaki-Faldami A
    Hell Stomatol Chron; 1985; 29(2):82-7. PubMed ID: 3870210
    [No Abstract]   [Full Text] [Related]  

  • 16. Single drug therapy for Helicobacter pylori infection.
    Miskovitz P; Cooper R; Nagler J
    Am J Gastroenterol; 2000 Oct; 95(10):2996. PubMed ID: 11051395
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
    Lee JW; Kim N; Nam RH; Lee SM; Soo In C; Kim JM; Lee DH
    J Gastroenterol Hepatol; 2019 Apr; 34(4):666-672. PubMed ID: 30726563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
    Sezgin O; Altintaş E; Nayir E; Uçbilek E
    Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
    Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
    Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin.
    Wu H; Shi XD; Wang HT; Liu JX
    J Antimicrob Chemother; 2000 Jul; 46(1):121-3. PubMed ID: 10882700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.